0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antithyroid Drug Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-30T6788
Home | Market Reports | Health| Pharmacy
Global Antithyroid Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Antithyroid Drug Market Research Report 2025

Code: QYRE-Auto-30T6788
Report
July 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antithyroid Drug Market

The global market for Antithyroid Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Antithyroid drug is a drug for the treatment of hyperthyroidism. It mainly reduces the secretion of thyroid hormone by inhibiting thyroid synthesis.
North American market for Antithyroid Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Antithyroid Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Antithyroid Drug include Pfizer Inc, Merck KGaA, Par Pharmaceutical, Teva Pharmaceuticals, Avet Pharmaceuticals Inc., Hemony Pharmaceutical, Zhaohui Pharmaceutical, YanJing Pharm, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antithyroid Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antithyroid Drug.
The Antithyroid Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antithyroid Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antithyroid Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antithyroid Drug Market Report

Report Metric Details
Report Name Antithyroid Drug Market
Segment by Type
  • Methimazole
  • Propylthiouracil
  • Other
Segment by Application
  • Hospital
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer Inc, Merck KGaA, Par Pharmaceutical, Teva Pharmaceuticals, Avet Pharmaceuticals Inc., Hemony Pharmaceutical, Zhaohui Pharmaceutical, YanJing Pharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Antithyroid Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Antithyroid Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Antithyroid Drug Market report?

Ans: The main players in the Antithyroid Drug Market are Pfizer Inc, Merck KGaA, Par Pharmaceutical, Teva Pharmaceuticals, Avet Pharmaceuticals Inc., Hemony Pharmaceutical, Zhaohui Pharmaceutical, YanJing Pharm

What are the Application segmentation covered in the Antithyroid Drug Market report?

Ans: The Applications covered in the Antithyroid Drug Market report are Hospital, Pharmacy, Other

What are the Type segmentation covered in the Antithyroid Drug Market report?

Ans: The Types covered in the Antithyroid Drug Market report are Methimazole, Propylthiouracil, Other

1 Antithyroid Drug Market Overview
1.1 Product Definition
1.2 Antithyroid Drug by Type
1.2.1 Global Antithyroid Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Methimazole
1.2.3 Propylthiouracil
1.2.4 Other
1.3 Antithyroid Drug by Application
1.3.1 Global Antithyroid Drug Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Antithyroid Drug Market Size Estimates and Forecasts
1.4.1 Global Antithyroid Drug Revenue 2020-2031
1.4.2 Global Antithyroid Drug Sales 2020-2031
1.4.3 Global Antithyroid Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Antithyroid Drug Market Competition by Manufacturers
2.1 Global Antithyroid Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Antithyroid Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Antithyroid Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Antithyroid Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antithyroid Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antithyroid Drug, Product Type & Application
2.7 Global Key Manufacturers of Antithyroid Drug, Date of Enter into This Industry
2.8 Global Antithyroid Drug Market Competitive Situation and Trends
2.8.1 Global Antithyroid Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antithyroid Drug Players Market Share by Revenue
2.8.3 Global Antithyroid Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antithyroid Drug Market Scenario by Region
3.1 Global Antithyroid Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Antithyroid Drug Sales by Region: 2020-2031
3.2.1 Global Antithyroid Drug Sales by Region: 2020-2025
3.2.2 Global Antithyroid Drug Sales by Region: 2026-2031
3.3 Global Antithyroid Drug Revenue by Region: 2020-2031
3.3.1 Global Antithyroid Drug Revenue by Region: 2020-2025
3.3.2 Global Antithyroid Drug Revenue by Region: 2026-2031
3.4 North America Antithyroid Drug Market Facts & Figures by Country
3.4.1 North America Antithyroid Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Antithyroid Drug Sales by Country (2020-2031)
3.4.3 North America Antithyroid Drug Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antithyroid Drug Market Facts & Figures by Country
3.5.1 Europe Antithyroid Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Antithyroid Drug Sales by Country (2020-2031)
3.5.3 Europe Antithyroid Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antithyroid Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Antithyroid Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Antithyroid Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Antithyroid Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Antithyroid Drug Market Facts & Figures by Country
3.7.1 Latin America Antithyroid Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Antithyroid Drug Sales by Country (2020-2031)
3.7.3 Latin America Antithyroid Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Antithyroid Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Antithyroid Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Antithyroid Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Antithyroid Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antithyroid Drug Sales by Type (2020-2031)
4.1.1 Global Antithyroid Drug Sales by Type (2020-2025)
4.1.2 Global Antithyroid Drug Sales by Type (2026-2031)
4.1.3 Global Antithyroid Drug Sales Market Share by Type (2020-2031)
4.2 Global Antithyroid Drug Revenue by Type (2020-2031)
4.2.1 Global Antithyroid Drug Revenue by Type (2020-2025)
4.2.2 Global Antithyroid Drug Revenue by Type (2026-2031)
4.2.3 Global Antithyroid Drug Revenue Market Share by Type (2020-2031)
4.3 Global Antithyroid Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Antithyroid Drug Sales by Application (2020-2031)
5.1.1 Global Antithyroid Drug Sales by Application (2020-2025)
5.1.2 Global Antithyroid Drug Sales by Application (2026-2031)
5.1.3 Global Antithyroid Drug Sales Market Share by Application (2020-2031)
5.2 Global Antithyroid Drug Revenue by Application (2020-2031)
5.2.1 Global Antithyroid Drug Revenue by Application (2020-2025)
5.2.2 Global Antithyroid Drug Revenue by Application (2026-2031)
5.2.3 Global Antithyroid Drug Revenue Market Share by Application (2020-2031)
5.3 Global Antithyroid Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer Inc
6.1.1 Pfizer Inc Company Information
6.1.2 Pfizer Inc Description and Business Overview
6.1.3 Pfizer Inc Antithyroid Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Inc Antithyroid Drug Product Portfolio
6.1.5 Pfizer Inc Recent Developments/Updates
6.2 Merck KGaA
6.2.1 Merck KGaA Company Information
6.2.2 Merck KGaA Description and Business Overview
6.2.3 Merck KGaA Antithyroid Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck KGaA Antithyroid Drug Product Portfolio
6.2.5 Merck KGaA Recent Developments/Updates
6.3 Par Pharmaceutical
6.3.1 Par Pharmaceutical Company Information
6.3.2 Par Pharmaceutical Description and Business Overview
6.3.3 Par Pharmaceutical Antithyroid Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Par Pharmaceutical Antithyroid Drug Product Portfolio
6.3.5 Par Pharmaceutical Recent Developments/Updates
6.4 Teva Pharmaceuticals
6.4.1 Teva Pharmaceuticals Company Information
6.4.2 Teva Pharmaceuticals Description and Business Overview
6.4.3 Teva Pharmaceuticals Antithyroid Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva Pharmaceuticals Antithyroid Drug Product Portfolio
6.4.5 Teva Pharmaceuticals Recent Developments/Updates
6.5 Avet Pharmaceuticals Inc.
6.5.1 Avet Pharmaceuticals Inc. Company Information
6.5.2 Avet Pharmaceuticals Inc. Description and Business Overview
6.5.3 Avet Pharmaceuticals Inc. Antithyroid Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Avet Pharmaceuticals Inc. Antithyroid Drug Product Portfolio
6.5.5 Avet Pharmaceuticals Inc. Recent Developments/Updates
6.6 Hemony Pharmaceutical
6.6.1 Hemony Pharmaceutical Company Information
6.6.2 Hemony Pharmaceutical Description and Business Overview
6.6.3 Hemony Pharmaceutical Antithyroid Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hemony Pharmaceutical Antithyroid Drug Product Portfolio
6.6.5 Hemony Pharmaceutical Recent Developments/Updates
6.7 Zhaohui Pharmaceutical
6.7.1 Zhaohui Pharmaceutical Company Information
6.7.2 Zhaohui Pharmaceutical Description and Business Overview
6.7.3 Zhaohui Pharmaceutical Antithyroid Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Zhaohui Pharmaceutical Antithyroid Drug Product Portfolio
6.7.5 Zhaohui Pharmaceutical Recent Developments/Updates
6.8 YanJing Pharm
6.8.1 YanJing Pharm Company Information
6.8.2 YanJing Pharm Description and Business Overview
6.8.3 YanJing Pharm Antithyroid Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 YanJing Pharm Antithyroid Drug Product Portfolio
6.8.5 YanJing Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antithyroid Drug Industry Chain Analysis
7.2 Antithyroid Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antithyroid Drug Production Mode & Process Analysis
7.4 Antithyroid Drug Sales and Marketing
7.4.1 Antithyroid Drug Sales Channels
7.4.2 Antithyroid Drug Distributors
7.5 Antithyroid Drug Customer Analysis
8 Antithyroid Drug Market Dynamics
8.1 Antithyroid Drug Industry Trends
8.2 Antithyroid Drug Market Drivers
8.3 Antithyroid Drug Market Challenges
8.4 Antithyroid Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Antithyroid Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Antithyroid Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Antithyroid Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Antithyroid Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Antithyroid Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Antithyroid Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Antithyroid Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Antithyroid Drug Average Price (US$/Units) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Antithyroid Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Antithyroid Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Antithyroid Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Antithyroid Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Antithyroid Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithyroid Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antithyroid Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Antithyroid Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Antithyroid Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Antithyroid Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Antithyroid Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Antithyroid Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Antithyroid Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Antithyroid Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Antithyroid Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Antithyroid Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Antithyroid Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Antithyroid Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Antithyroid Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Antithyroid Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Antithyroid Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Antithyroid Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Antithyroid Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Antithyroid Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Antithyroid Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Antithyroid Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Antithyroid Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Antithyroid Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Antithyroid Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Antithyroid Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Antithyroid Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Antithyroid Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Antithyroid Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Antithyroid Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Antithyroid Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Antithyroid Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Antithyroid Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Antithyroid Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Antithyroid Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Antithyroid Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Antithyroid Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Antithyroid Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Antithyroid Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Antithyroid Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Antithyroid Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Antithyroid Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Antithyroid Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Antithyroid Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Antithyroid Drug Price (US$/Units) by Type (2020-2025)
 Table 59. Global Antithyroid Drug Price (US$/Units) by Type (2026-2031)
 Table 60. Global Antithyroid Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Antithyroid Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Antithyroid Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Antithyroid Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Antithyroid Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Antithyroid Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Antithyroid Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Antithyroid Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Antithyroid Drug Price (US$/Units) by Application (2020-2025)
 Table 69. Global Antithyroid Drug Price (US$/Units) by Application (2026-2031)
 Table 70. Pfizer Inc Company Information
 Table 71. Pfizer Inc Description and Business Overview
 Table 72. Pfizer Inc Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Units) and Gross Margin (2020-2025)
 Table 73. Pfizer Inc Antithyroid Drug Product
 Table 74. Pfizer Inc Recent Developments/Updates
 Table 75. Merck KGaA Company Information
 Table 76. Merck KGaA Description and Business Overview
 Table 77. Merck KGaA Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Units) and Gross Margin (2020-2025)
 Table 78. Merck KGaA Antithyroid Drug Product
 Table 79. Merck KGaA Recent Developments/Updates
 Table 80. Par Pharmaceutical Company Information
 Table 81. Par Pharmaceutical Description and Business Overview
 Table 82. Par Pharmaceutical Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Units) and Gross Margin (2020-2025)
 Table 83. Par Pharmaceutical Antithyroid Drug Product
 Table 84. Par Pharmaceutical Recent Developments/Updates
 Table 85. Teva Pharmaceuticals Company Information
 Table 86. Teva Pharmaceuticals Description and Business Overview
 Table 87. Teva Pharmaceuticals Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Units) and Gross Margin (2020-2025)
 Table 88. Teva Pharmaceuticals Antithyroid Drug Product
 Table 89. Teva Pharmaceuticals Recent Developments/Updates
 Table 90. Avet Pharmaceuticals Inc. Company Information
 Table 91. Avet Pharmaceuticals Inc. Description and Business Overview
 Table 92. Avet Pharmaceuticals Inc. Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Units) and Gross Margin (2020-2025)
 Table 93. Avet Pharmaceuticals Inc. Antithyroid Drug Product
 Table 94. Avet Pharmaceuticals Inc. Recent Developments/Updates
 Table 95. Hemony Pharmaceutical Company Information
 Table 96. Hemony Pharmaceutical Description and Business Overview
 Table 97. Hemony Pharmaceutical Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Units) and Gross Margin (2020-2025)
 Table 98. Hemony Pharmaceutical Antithyroid Drug Product
 Table 99. Hemony Pharmaceutical Recent Developments/Updates
 Table 100. Zhaohui Pharmaceutical Company Information
 Table 101. Zhaohui Pharmaceutical Description and Business Overview
 Table 102. Zhaohui Pharmaceutical Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Units) and Gross Margin (2020-2025)
 Table 103. Zhaohui Pharmaceutical Antithyroid Drug Product
 Table 104. Zhaohui Pharmaceutical Recent Developments/Updates
 Table 105. YanJing Pharm Company Information
 Table 106. YanJing Pharm Description and Business Overview
 Table 107. YanJing Pharm Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Units) and Gross Margin (2020-2025)
 Table 108. YanJing Pharm Antithyroid Drug Product
 Table 109. YanJing Pharm Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Antithyroid Drug Distributors List
 Table 113. Antithyroid Drug Customers List
 Table 114. Antithyroid Drug Market Trends
 Table 115. Antithyroid Drug Market Drivers
 Table 116. Antithyroid Drug Market Challenges
 Table 117. Antithyroid Drug Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antithyroid Drug
 Figure 2. Global Antithyroid Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antithyroid Drug Market Share by Type: 2024 & 2031
 Figure 4. Methimazole Product Picture
 Figure 5. Propylthiouracil Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Antithyroid Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Antithyroid Drug Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Pharmacy
 Figure 11. Other
 Figure 12. Global Antithyroid Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Antithyroid Drug Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Antithyroid Drug Sales (2020-2031) & (K Units)
 Figure 15. Global Antithyroid Drug Average Price (US$/Units) & (2020-2031)
 Figure 16. Antithyroid Drug Report Years Considered
 Figure 17. Antithyroid Drug Sales Share by Manufacturers in 2024
 Figure 18. Global Antithyroid Drug Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Antithyroid Drug Players: Market Share by Revenue in Antithyroid Drug in 2024
 Figure 20. Antithyroid Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Antithyroid Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Antithyroid Drug Sales Market Share by Country (2020-2031)
 Figure 23. North America Antithyroid Drug Revenue Market Share by Country (2020-2031)
 Figure 24. United States Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Antithyroid Drug Sales Market Share by Country (2020-2031)
 Figure 27. Europe Antithyroid Drug Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Antithyroid Drug Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Antithyroid Drug Revenue Market Share by Region (2020-2031)
 Figure 35. China Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Antithyroid Drug Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Antithyroid Drug Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Colombia Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Antithyroid Drug Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Antithyroid Drug Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Antithyroid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Antithyroid Drug by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Antithyroid Drug by Type (2020-2031)
 Figure 57. Global Antithyroid Drug Price (US$/Units) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Antithyroid Drug by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Antithyroid Drug by Application (2020-2031)
 Figure 60. Global Antithyroid Drug Price (US$/Units) by Application (2020-2031)
 Figure 61. Antithyroid Drug Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart